FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce a COVID-19 vaccine as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.
One in three American adults has high blood pressure. To combat this, Dr. Roozbeh Jafari and his team received a $3.6 million grant from the National Institutes of Health to create a blood pressure system a user can wear all night while they sleep for constant readings.
The National Center for Therapeutics Manufacturing is producing spike proteins to identify antibodies that can attach to the SARS-CoV-2 spike protein receptor-binding domain and prevent the virus from binding to key sites, thus obstructing the virus from entering and infecting human cells.
Dr. Amir Asadi and a team of researchers have developed a new manufacturing process for hybrid polymer composites – a vital component in the aerospace, automotive, marine and defense industries.
The first workshop of the Deep Tech Talk Webinar Series will be presented on July 13 at 8 a.m. This webinar series will present and discuss experiences from around the world about the path for commercialization of deep technologies that advance scientific frontiers.
Texas A&M researchers have discovered how to use electron beam irradiation to effectively decontaminate and recycle personal protective equipment such as N95 masks, surgical masks, face shields and gowns for health care professionals.
Col. Rosendo “Ross” Guieb has been named as the first executive director of the George H.W. Bush Combat Development Complex. Guieb, a former Army Futures Command senior staff member, will help modernize the Army.
